COMPANY｜Biolinks Co., Ltd.

COMPANY

Location	Head Office 18-6, Takayama, Tsuzuki-ku, Yokohama Kanagawa, Japan
Established	June, 1989
Paid-in Capital	50 million yen
Board of Directors	President and CEO Munehiro Fujisawa Senior Managing Director Hisako Fujisawa Factory Director Keiichi Kambara Director Takeyoshi Kusayanagi
Primary Business Domain	Developing and marketing diagnostics
Group Companies	Fujitechs Co., Ltd.
Client Companies	Sysmex Corporation Kyokuto Pharmaceutical Industrial Co., Ltd. Infinita Co., Ltd. CPH Co., Ltd(Associated company in Chinese business) Japan Lyophilization Laboratory Japan BCG Laboratory
Main financing Banks	MUFG Bank, Ltd. The Bank of Yokohana, Ltd. The Shizuoka Chuo Bank, Ltd.

June, 1989	Established in Komae, Tokyo
September, 1992	Established Yokohama Laboratory
October, 1993	Obtained Manufacturering Business License of drugs
May, 1995	Moved Head Office to Tama, Tokyo
December, 1997	Completed our own building
October, 1998	Applied for the patent with　Terumo Corporation as "blood collection tube with FDP granule."
February, 1999	Obtained license of P-FDP reagent
December, 2005	Obtained ISO13485:2003 certification
April, 2005	Obtained the Second Class Drugs Marketing Authorization Holder License
January, 2007	Obtained license of Cystatin C reagent
August, 2008	Succeeded the factory of MedicalLink Co., Ltd
August, 2008	Obtained the patent with Morinaga Milk Industry Co., Ltd. as ”quantitative measurement method of lactoferrin in foods.”
September, 2009	Obtained license of H-FABP reagent
October, 2016	Obtained license of H-FABP detection kit
December, 2017	Moved Head Office to Yokohama, Kanagawa
September, 2018	Obtained license of IgG4 reagent
September, 2019	Made Medicallink Co., Ltd. and Fujitechs Co., Ltd. a subsidiaries
December, 2020	Obtained license of PCT semi-quantitative kit
January, 2021	Changed the president due to the death of the founder
April, 2022	Merged with subsidiary Medicallink Co., Ltd.